Dmpl Pharmaceuticals Private Limited, a active private limited company, was established on 05 October 2016 in Dombivali Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2016PTC286559. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Genesun Pharma Private Limited. It upholds a compliant status. Its leadership includes Vikesh Premnath Upadhyay (Additional Director), Sunny Kumar Prem Nath Upadhaya (Director). Past directors included Rangnayaki Sunny Upadhyay, Chandrabhushan Rambharose Pande. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No. X-25/9-21, Gala No. 20 First Floor, Gaondevi Shopping Center Midc Dombivali, East, Dombivali Thane, Maharashtra, 421203.
U74999MH2016PTC286559
286559
05 October 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dmpl Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikesh Premnath Upadhyay | Additional Director | 09 Jan 2017 | Current |
| Sunny Kumar Prem Nath Upadhaya | Director | 05 Oct 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 05 Feb 2018 | Past |
| Pramod Abcsdd | Director | 24 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dmpl Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 431.72% increase. The company also saw a substantial fall in profitability, with a 9891.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 479.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dmpl Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dmpl Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dmpl Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dmpl Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dmpl Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on Dmpl Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
Progress on Vikesh Premnath Upadhyay was appointed as a Additional Director was appointed as a Additional Director on 09 Jan 2017 & has been associated with this company since 8 years 10 months . was documented.
The activity Sunny Kumar Prem Nath Upadhaya was appointed as a Director was appointed as a Director on 05 Oct 2016 & has been associated with this company since 9 years 1 month . was completed.
The activity Dmpl Pharmaceuticals Private Limited was registered on 05 Oct 2016 with Roc Mumbai & aged 9 years 1 month as per MCA records. was completed.
The CIN of Dmpl Pharmaceuticals Private Limited is U74999MH2016PTC286559.
Dmpl Pharmaceuticals Private Limited is headquartered at Plot No. X-25/9-21, Gala No. 20 First Floor, Gaondevi Shopping Center Midc Dombivali, East, Dombivali Thane, Maharashtra, 421203.
Dmpl Pharmaceuticals Private Limited was incorporated on 05 October 2016.
The current directors of Dmpl Pharmaceuticals Private Limited are
The primary industry of Dmpl Pharmaceuticals Private Limited is Trade.
Dmpl Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dmpl Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dmpl Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX